Roche Lietuva - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 55,075,951 | 50,616,304 | 55,321,612 | 59,861,366 | 61,528,448 | 59,460,371 | 72,441,577 | 79,030,189 |
| Profit before tax | 2,148,083 | 2,863,041 | 2,743,599 | 2,574,087 | 2,475,912 | 2,326,273 | 2,819,724 | 2,783,934 |
| Net profit | 1,815,411 | 2,422,161 | 2,302,152 | 2,158,289 | 2,041,087 | 1,780,554 | 2,284,138 | 2,266,849 |
| Equity | 18,085,807 | 21,241,367 | 23,891,732 | 26,050,021 | 28,091,108 | 25,871,662 | 28,155,800 | 30,422,649 |
| Liabilities | 11,333,256 | 8,691,637 | 14,324,272 | 12,318,819 | 12,726,999 | 13,169,528 | 11,247,663 | 20,099,925 |
| Non-current assets | 2,781,211 | 2,272,776 | 2,700,355 | 3,723,289 | 4,072,665 | 5,357,862 | 5,242,877 | 5,240,465 |
| Current assets | 27,268,161 | 27,762,763 | 34,983,569 | 34,001,964 | 36,626,779 | 34,343,302 | 36,644,962 | 49,502,872 |
| Total assets | 30,049,372 | 30,035,539 | 37,683,924 | 37,725,253 | 40,699,444 | 39,701,164 | 41,887,839 | 54,743,337 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,758,868 | 5,304,762 | 5,740,649 |
| Social insurance contributions | - | - | - | - | - | 1,229,162 | 1,204,983 | 1,234,705 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3.9% | -8.1% | +9.3% | +8.2% | +2.8% | -3.4% | +21.8% | +9.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.0% | 8.1% | 6.1% | 5.7% | 5.0% | 4.5% | 5.5% | 4.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.0% | 11.4% | 9.6% | 8.3% | 7.3% | 6.9% | 8.1% | 7.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.3% | 4.8% | 4.2% | 3.6% | 3.3% | 3.0% | 3.2% | 2.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.9% | 5.7% | 5.0% | 4.3% | 4.0% | 3.9% | 3.9% | 3.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.4 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 761,419 | 706,274 | 790,309 | 821,896 | 837,122 | 839,441 | 1,053,696 | 1,115,721 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Roche Lietuva - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-12-01 | 2021-12-01 | 53.25 |
Roche Lietuva - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-31 | 2025-07-31 | 919.43 |
| 2025-07-30 | 2025-07-30 | 318.59 |
| 2025-07-10 | 2025-07-20 | 62.61 |
| 2025-07-18 | 2025-07-20 | 13.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Roche Lietuva, UAB (code 300089404) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, revenue reached €79.03M, up 9.1% year on year and 32.9% over two years. Net profit was €2.27M, broadly in line with €2.28M in 2024 and above €1.78M in 2023, showing steady profitability despite rapid sales growth. The profit margin was 2.9% in 2025, slightly below 3.2% in 2024 and 3.0% in 2023. The balance sheet expanded, with total assets rising to €54.74M, equity increasing to €30.42M, and liabilities moving to €20.10M. The equity ratio stood at 55.6%, while debt-to-equity was 0.66, indicating a conservative capital structure. Return on equity was 7.5% and return on assets 4.1%. Asset turnover was 1.44x, supported by short-term assets of €49.50M and long-term assets of €5.24M. Revenue per employee was €1.13M and profit per employee €32.4K.